Richard Vincent

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Secretary, Director Sorrento Therapeutics Inc Sept. 1, 2012 - Jan. 30, 2015
Part-time Chief Financial Officer Sorrento Therapeutics Inc Feb. 5, 2010 - Sept. 1, 2012
Richard Vincent's trades of Oncternal Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-14 2023-04-13
B Purchase
98,725 -16.8%
241.76
US$3,108,385 		98,725 -16.8% 241.76 US$3,108,385
2022-03-28 2022-03-28
B Purchase
1,533 -29.6%
294.08
US$1,562,505 		1,533 -29.6% 294.08 US$1,562,505
2022-03-28 2022-03-25
B Purchase
26,689 -46.7%
173.37
US$86,772 		26,689 -46.7% 173.37 US$86,772
2022-03-28 2022-03-25
B Purchase
5 +0.0%
1.48
US$7 		5 +0.0% 1.48 US$7
2022-03-28 2022-03-25
B Purchase
356 +0.4%
1.45
US$516 		356 +0.4% 1.45 US$516
2022-03-28 2022-03-24
B Purchase
3 +0.0%
1.45
US$4 		3 +0.0% 1.45 US$4
2022-01-31 2022-01-28
B Purchase
2,500 +3.1%
1.65
US$4,125 		2,500 +3.1% 1.65 US$4,125
2022-01-31 2022-01-27
B Purchase
5,000 +6.6%
1.70
US$8,500 		5,000 +6.6% 1.70 US$8,500
2022-01-31 2022-01-27
B Purchase
5,000 +7.1%
1.80
US$9,000 		5,000 +7.1% 1.80 US$9,000